Epstein-Barr virus BamHI-A rightward transcript-encoded RPMS protein interacts with the CBF1-associated corepressor CIR to negatively regulate the activity of EBNA2 and NotchIC

Journal of Virology

Volumn 75, Issue 6, 2001, Pages 2946-2956

  Zhang, J ^a   Chen, H ^a   Weinmaster, G ^a   Hayward, S D ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE TRANSFERASE; NUCLEAR PROTEIN; PROTEIN; PROTEIN EBNA2; PROTEIN NOTCHIC; RPMS PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; INFECTION; LYMPHOBLASTOID CELL LINE; MUSCLE CELL; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; RNA SPLICING; TRANSCRIPTION REGULATION;

CELL DIFFERENTIATION; CELL LINE; DEOXYRIBONUCLEASE BAMHI; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRUS 4, HUMAN; HUMANS; MEMBRANE PROTEINS; MUSCLES; NEOPLASM PROTEINS; RECEPTORS, NOTCH; REPRESSOR PROTEINS; RNA, MESSENGER; RNA, VIRAL; TRANSCRIPTION, GENETIC; TRANSFECTION; VIRAL PROTEINS;

EID: 0035129844     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.6.2946-2956.2001     Document Type: Article

References (62)

1. Notch signaling: Cell fate control and signal integration in development
2. Transcripts from the Epstein-Barr virus BamHI A fragment are detectable in all three forms of virus latency
3. Notch1-induced delay of human hematopoietic progenitor cell differentiation is associated with altered cell cycle kinetics
4. Expression of Epstein-Barr virus BamHI-A rightward transcripts (BARTs) in latently infected B cells from peripheral blood
5. Transcription of BamHI-A region of the EBV genome in NPC tissues and B cells
6. Nasal NK- and T-cell lymphomas share the same type of Epstein-Barr virus latency as nasopharyngeal carcinoma and Hodgkin's disease
7. Epstein-Barr virus and Hodgkin's disease: Transcriptional analysis of virus latency in the malignant cells
8. A presenilin-1-dependent γ-secretase-like protease mediates release of Notch intracellular domain
9. An activated Notch receptor blocks cell-fate commitment in the developing Drosophila eye
10. Identification of a novel protein encoded by the BamHI A region of the Epstein-Barr virus
11. Novel transcription from the Epstein-Barr virus terminal EcoRI fragment, DIJhet, in a nasopharyngeal carcinoma
12. Expression of the Epstein-Barr virus BamHI A fragment in nasopharyngeal carcinoma: Evidence for viral protein expressed in vivo
13. Lin-12/Notch signaling: Lessons from worms and flies
14. The Epstein-Barr virus nuclear antigen 2 transactivator is directed to response elements by the Jκ recombination signal binding protein
15. Immortalization by Epstein-Barr virus: Focusing on the Notch signaling pathway
16. Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein Jκ
17. EBV gene expression in an NPC-related tumor
18. Masking of the CBF1/RBPJκ transcriptional repression domain by Epstein-Barr virus EBNA2
19. Truncated mammalian Notchl activates CBF1/RBPJκ-repressed genes by a mechanism resembling that of Epstein-Barr virus EBNA2
20. EBV immortalization: Notch2 interacts with CBF1 and blocks differentiation
21. CIR, a corepressor linking the DNA binding factor CBF1 to the histone deacetylase complex
22. Characterization of a new EBV-associated nasopharyngeal carcinoma cell line
23. Signalling downstream of activated mammalian Notch
24. Three unrelated viral transforming proteins (vIRF, EBNA2, and E1A) induce the MYC oncogene through the interferon-responsive PRF element by using different transcription coadaptors
25. EBNA-2 and EBNA-3C extensively and mutually exclusively associate with RBPJκ in Epstein-Barr virus-transformed B lymphocytes
26. A histone deacetylase corepressor complex regulates the Notch signal transduction pathway
27. Expression of a family of complementary-strand transcripts in Epstein-Barr virus-infected cells
28. Immortalization of human B lymphocytes by a plasmid containing 71 kilo-base pairs of Epstein-Barr virus DNA
29. Epstein-Barr virus-encoded RK-BARF0 protein expression
30. Identification of a cytotoxic T-lymphocyte response to the novel BARF0 protein of Epstein-Barr virus: A critical role for antigen expression
31. The intracellular domain of mouse Notch: A constitutively activated repressor of myogenesis directed at the basic helix-loop-helix region of MyoD
32. Functional interaction between the mouse notchl intracellular region and histone acetyltransferases PCAF and GCN5
33. SAP30, a component of the mSin3 corepressor complex involved in N-CoR-mediated repression by specific transcription factors
34. Antineurogenic phenotypes induced by truncated Notch proteins indicate a role in signal transduction and may point to a novel function for Notch in nuclei
35. The Epstein-Barr virus immortalizing protein EBNA-2 is targeted to DNA by a cellular enhancer-binding protein
36. EBNA-2 of herpesvirus papio diverges significantly from the type A and type B EBNA-2 proteins of Epstein-Barr virus but retains an efficient transactivation domain with a conserved hydrophobic motif
37. Stimulation of human epidermal differentiation by delta-notch signalling at the boundaries of stem-cell clusters
38. Arbiter of differentiation and death: Notch signaling meets apoptosis
39. Identification of the site of Epstein-Barr virus persistence in vivo as a resting B cell
40. A novel form of Epstein-Barr virus latency in normal B cells in vivo
41. Notch signaling imposes two distinct blocks in the differentiation of C2C12 myoblasts
42. Notchl expression in early lymphopoiesis influences B versus T lineage determination
43. An Epstein-Barr virus with a 58-kilobase-pair deletion that includes BARF0 transforms B lymphocytes in vitro
44. Structural analyses of the Epstein-Barr virus BamHI A transcripts
45. Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain
46. Structure and coding content of CST (BART) family RNAs of Epstein-Barr virus
47. Complex nature of the major viral polyadenylated transcripts in Epstein-Barr virus-associated tumors
48. Nuclear access and action of Notch in vivo
49. Intrinsic activity of the Lin-12 and Notch intracellular domains in vivo
50. Presenilin is required for activity and nuclear access of Notch in Drosophila
51. Transcriptional analysis of Epstein-Barr virus gene expression in EBV-positive gastric carcinoma: Unique viral latency in the tumor cells
52. Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation
53. The human Jκ recombination signal sequence binding protein (RBP-Jκ) targets the Epstein-Barr virus EBNA2 protein to its DNA responsive elements
54. Epstein-Barr virus EBNA3A and EBNA3C proteins both repress RBP-Jκ-EBNA2-activated transcription by inhibiting the binding of RBP-Jκ to DNA
55. Epstein-Barr virus nuclear protein 2 interacts with p300, CBP, and PCAF histone acetyltransferases in activation of the LMP1 promoter
56. Transcription of Epstein-Barr virus latent cycle genes in oral hairy leukoplakia
57. The ins and outs of Notch signaling
58. Neurogenic phenotypes and altered Notch processing in Drosophila Presenilin mutants
59. A conserved domain of the Epstein-Barr virus nuclear antigens 3A and 3C binds to a discrete domain of Jκ
60. A role for SKIP in EBNA2 activation of CBF1-repressed promoters
61. SKIP, a CBF1-associated protein, interacts with the ankyrin repeat domain of NotchIC to facilitate NotchIC function
62. Epstein-Barr virus nuclear antigen 2 exerts its transactivating function through interaction with recombination signal binding protein RBP-J kappa, the homologue of Drosophila Suppressor of Hairless